Related Experiment Video

Updated: May 30, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Antibiotic treatment schemes for very severe community-acquired pneumonia in children: a randomized clinical study

Cristiane Franco Ribeiro1, Giesela Fleisher Ferrari, José Roberto Fioretto

  • 1Departamento de Pediatria, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.

Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|August 11, 2011
PubMed

Insights

Amoxicillin/clavulanic acid showed faster improvement in tachypnea for children with severe pneumonia compared to oxacillin/ceftriaxone. Both antibiotic regimens effectively treated severe community-acquired pneumonia (CAP) in hospitalized children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Severe community-acquired pneumonia (CAP) is a significant cause of pediatric hospitalization.
  • Empiric antibiotic selection is crucial for effective CAP management in children.
  • Limited comparative data exists for specific empiric antibiotic regimens in very severe pediatric CAP.

Purpose of the Study:

  • To compare the clinical effectiveness of oxacillin plus ceftriaxone versus amoxicillin plus clavulanic acid as initial empiric treatment for very severe CAP in hospitalized children.
  • To evaluate key clinical outcomes including time to improvement, oxygen therapy duration, and hospitalization length.

Main Methods:

  • A prospective randomized clinical study involved 104 children (2 months to 5 years) with very severe CAP.
  • Patients were randomized into two groups: oxacillin/ceftriaxone (n=48) or amoxicillin/clavulanic acid (n=56).
  • Outcomes assessed included time to clinical improvement (fever, tachypnea), oxygen therapy duration, hospital stay, and complications.

Main Results:

  • Amoxicillin/clavulanic acid group showed a statistically significant shorter time to improve tachypnea (4.8 vs 5.8 days, P=0.028).
  • The amoxicillin/clavulanic acid group also had a significantly shorter length of hospital stay (11.0 vs 14.4 days, P=0.002).
  • No significant differences were observed in fever improvement, oxygen therapy duration, need for broader-spectrum antibiotics, or pleural effusion rates.

Conclusions:

  • Both oxacillin/ceftriaxone and amoxicillin/clavulanic acid are effective empiric treatments for very severe CAP in hospitalized children aged 2 months to 5 years.
  • Amoxicillin/clavulanic acid demonstrated a faster resolution of tachypnea as a key clinical benefit.
  • The choice between these regimens may consider the observed differences in tachypnea resolution and hospital stay.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.